跳至主要内容
临床试验/JPRN-UMIN000015427
JPRN-UMIN000015427招募中未知

Prognostic Assessment for Patients Notified as Dual Obstructive Atherosclerosis Requiring Angioplasties - PANDORA Registry

Department of Cardiology, Fujita Health University0 个研究点目标入组 300 人开始时间: 2014年11月1日最近更新:
适应症

试验速览

阶段
未知
状态
招募中
发起方
入组人数
300

研究概览

简要总结

The prevalence of TVD/LMT and HRP determined by coronary CTA is higher in patients needing CAS/CEA than in those without. Management of systemic atherosclerosis is required in the perioperative period of CAS/CEA.

研究设计

研究类型
Observational

入排标准

年龄范围
20years-old 至 ot applicable(—)
性别
All

入选标准

  • 未提供

排除标准

  • Those who underwent coronary artery bypass grafting Those who have severe chronic lidney disease (estimated glomerular filtration rate <30mL/min/1.73m2) Those who have iodinated contrast medium allergy Those who are not willing to participate in the study

研究者

发起方
Department of Cardiology, Fujita Health University

相似试验